Novel Estrogen Receptor β/Histone Deacetylase Dual-Targeted Near-Infrared Fluorescent Probes as Theranostic Agents for Imaging and Treatment of Prostate Cancer

Scientists investigated the design and synthesis of the first estrogen receptor (ERβ) and histone deacetylases dual-target near-infrared fluorescent probe with both imaging capacity and antitumor activity for prostate cancer.